Skip to content

John L. Waddington

6 papers in the library · 16 citations · publishing 2010-2024

Papers

Sort Most recent Most cited

Overshadowing and salience attribution in relation to cannabis use

Schizophrenia Research: Cognition May 11, 2024 Christopher Dawes, Samuel Joy McGreal, Shivika Marwaha et al.

Aberrant attentional salience has been implicated in the cannabis-psychosis association. Here, history and frequency of cannabis use were examined against changes in overshadowing (OS), a cue competition paradigm that involves salience processing. Additionally, we examined the association between OS and alternative measures of aberrant salience, as well as schizotypy, in a non-clinical adult...

DOI: 10.1016/j.scog.2024.100315 (opens in new tab) Cannabis Salience neuroscience Attribution Relation database +3

Latent inhibition, aberrant salience, and schizotypy traits in cannabis users

Schizophrenia Research: Cognition January 5, 2022 Christopher Dawes, Declan Quinn, Andrea Bickerdike et al.

Aberrant salience processing may underlie the link between cannabis and psychosis, as posited in individuals with schizophrenia or high schizotypy. We investigated the relative effects of cannabis use, schizotypy status, and self-reported aberrant salience experiences on salience processing, measured using a latent inhibition (LI) task (Granger et al., 2016), in a non-clinical population. A...

Cannabis Use, Schizotypy and Kamin Blocking Performance

Frontiers in Psychiatry November 23, 2021 Christopher Dawes, Andrea Bickerdike, Cian O’Neill et al. 3 citations

Cannabis use has been associated with increased risk for a first episode of psychosis and inappropriate assignment of salience to extraneous stimuli has been proposed as a mechanism underlying this association. Psychosis-prone (especially schizotypal) personality traits are associated with deficits in associative learning tasks that measure salience allocation. The aim of this study was to...

DOI: 10.3389/fpsyt.2021.633476 (opens in new tab) Cannabis Schizotypy Psychosis Salience neuroscience +5

Does cannabis use predict psychometric schizotypy via aberrant salience?

Schizophrenia Research April 6, 2020 Colm O’Tuathaigh, Christopher Dawes, Andrea Bickerdike et al. 13 citations

Cannabis can induce acute psychotic symptoms in healthy individuals and exacerbate pre-existing psychotic symptoms in patients with schizophrenia. Inappropriate salience allocation is hypothesised to be central to the association between dopamine dysregulation and psychotic symptoms. This study examined whether cannabis use is associated with self-reported salience dysfunction and schizotypal...

DOI: 10.1016/j.schres.2020.03.021 (opens in new tab) Cannabis Schizotypy Schizotypal personality disorder Clinical psychology +6

Genetic dissection of the psychotomimetic effects of cannabinoid exposure.

Progress in Neuro-Psychopharmacology and Biological Psychiatry July 3, 2014 Colm M P O'Tuathaigh, Ilse Gantois, John L. Waddington

Cannabis use is an established risk factor for the development of schizophrenia and related psychotic disorders. Factors that may mediate susceptibility to the psychosis-inducing effects of cannabis include the age at onset of first cannabis use, genetic predisposition, as well as interaction with other environmental risk variables. Clinical and preclinical genetic studies provide increasing...

Chronic adolescent exposure to Δ-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes.

Neuropsychopharmacology October 2010 Colm M P O'Tuathaigh, Magdalena Hryniewiecka, Aine Behan et al.

Cannabis use confers a two-fold increase in the risk for psychosis, with adolescent use conferring even greater risk. A high-low activity catechol-O-methyltransferase (COMT) polymorphism may modulate the effects of adolescent Δ-9-tetrahydrocannabinol (THC) exposure on the risk for adult psychosis. Mice with knockout of the COMT gene were treated chronically with THC (4.0 and 8.0 mg/kg over 20...